Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Statera Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Statera Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Saluck Randy S. | Director | 60,140 | Oct 28, 2021 | 0 |
| Barbarick Steve K | Director | 60,000 | Oct 19, 2021 | 0 |
| Verny Lea | Director | 60,000 | Oct 19, 2021 | 0 |
| Markvicka Taunia | Chief Operating Officer | 100,000 | Sep 30, 2021 | 0 |
| Handley Michael K | President and CEO | 296,609 | Aug 4, 2021 | 0 |
| Aronstam Peter | Chief Financial Officer | 141,370 | Jul 29, 2021 | 0 |
| Selsky Clifford | Chief Medical Officer | 101,579 | Jul 29, 2021 | 0 |
| McAvoy Cozette M. | Chief Legal Officer | 60,947 | Jul 29, 2021 | 0 |
| Buckheit Robert | Chief Technology Officer | 24,378 | Jul 29, 2021 | 0 |
| Miller Langdon L | Chief Medical Officer | 10,000 | Jul 23, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.